A new naturally occurring flavonol diglycoside, tamarixetin 3-O-β-glucopyranoside -7-O-α-rhamnopyranoside, was isolated along with two known flavonol diglycosides from the aerial parts of Tephrosia purpurea (L.) Pers. (Fabaceae). Bioassay guided fractionation of the light petroleum extract afforded two bioactive 5-deoxyflavones, pseudosemiglabrin and glabratephrin. Both showed cytotoxicity to the Hepg2 hepatic human cell line with IC 50 values of 0.87 and 4.03 μg/mL, respectively. The isolated compounds were characterized by spectroscopic (UV, 1 H, 13 C, HMQC and HMBC NMR) and spectrometric (EI-MS, ESI-MS) analyses.
Tephrosia species (Fabaceae) possess antifungal, antibacterial and insecticidal activities [1] , as well as poisonous properties [2] . T. purpurea (L.) Pers. is used in traditional medicine as a tonic, laxative and anthelmentic for children [3] . It possesses significant activity against hepatotoxicity and alleviates phorbol ester-induced tumor promotion in murine skin [4] . Previous studies revealed that light petroleum extracts significantly induced quinone reductase activity with cultured Hepa 1c7 (mouse hepatoma) cells [1] . Flavonoids and isoflavonoids have been reported in several Tephrosia species [5] .
In the present study, the aerial parts of T. purpurea were extracted with light petroleum, followed by EtOAc and MeOH. The light petroleum extract showed in vitro antitumor activity and the major active constituents were isolated. The bioassayguided fractionation involved successive chromatographic separation on silica gel, TLC and Sephadex LH-20, which afforded two 5-deoxyflavone compounds, pseudosemiglabrin (1) and glabratephrin (2) [6, 7] . A new flavonol diglycoside, tamarixetin 3-O-β-glucopyranoside -7-O-α-rhamnopyranoside (3), together with kaempferol 3,7-di-O-α-rhamnopyranoside (4) and quercetin 3,7di-O-α-rhamnopyranoside (5) were isolated from the methanol extract using Polyamide column S6, PPC and Sephadex LH 20. Compounds (4) and (5) were identified using acid hydrolysis, which yielded rhamnose and kaempferol for (4), and rhamnose and quercetin for (5) [Co-PC], together with UV and 1 H NMR spectroscopic data which compared with published data [8] . Resonances of other sugar protons appeared overlapped with OH proton signals in the region δ 3.2-3.58. In the aromatic region, the 1 H NMR spectrum revealed two doublets at δ 6.38 and 6.77 (each 1H, J = 2 Hz), assignable to H-6 and H-8. Two doublets at δ 6.80 (1H, J = 9 Hz) and 7.58 (2H, J = 2 Hz) were attributed to H-5´ and H-2´,6´, indicating substitution at positions 3´ and 4´. These chemical shifts are in agreement with those reported for the corresponding proton resonances of tamarixetin 3,7-di-O-glycoside [10] . The 13 C NMR spectrum exhibited twelve distinct resonances, attributed to a β-glucopyranose and an α-rhamnopyranose moiety, respectively. The upfield shift (2 and 1.2 ppm) of the carbon resonances at δ 134 and 162 are attributed to C-3 and C-7, respectively, confirming their glycosylation pattern. These assignments were confirmed by HMBC spectra, which revealed a 3 J correlation between C-3 at δ 134 and the glucose H-1´´ at δ 5.45, C-7 at δ 162 and the rhamnose H-1´´´ at δ 5.55, and C-4´ at δ 149.3 and the methoxyl group at δ 3.60. Based on the above evidence, 3 was identified as tamarixetin 3-O-βglucopyranoside-7-O-α-rhamnopyranoside.
In vitro screening of pseudosemiglabrin (1) and glabratephrin (2) for cytotoxic activity against the human tumor cell lines U251 brain, MCF7 breast and Hepg2 liver carcinoma was carried out using the Sulforhodamine B assay (SRB assay) [11] . Concentrations of tested compounds were between (1.00-10.00 μg/mL). The results revealed that 1 and 2 possess cytotoxic activities against the human tumor cell line Hepg2, with observed IC 50 values 0.87 and 4.03 μg/mL, respectively, and are inactive against the U251 (brain tumor) and the MCF7 (breast carcinoma) cell lines. This is the first report of a bioassay test for the 5-deoxyflavone (glabratephrin). 
Extraction and isolation:
The ground aerial parts of T. purpurea (500 g) were subjected to successive extraction with light petroleum (60-80º), EtOAc, and methanol (each with 3L, in a Soxhlet apparatus). The light petroleum extract (90 g) was applied to a silica gel 60 column and eluted with light petroleum containing increasing concentrations of CHCl 3 . Purification was achieved by a combination of TLC (light petroleum: CHCl 3 : MeOH, 80: 20: 10) and Sephadex LH 20 chromatography. This afforded two compounds (1 and 2) , which were crystallized from CHCl 3 -MeOH to give 1 (450 mg) and 2 (200 mg).
The methanol soluble extract (70 g), was applied to a polyamide column S6 (Riedel-De-Haen AG, Seelze Haen AG, Seelze Hanover, Germany), 125 x 5 cm internal diameter, and eluted with water, followed by H 2 O-MeOH mixtures of decreasing polarities to yield eight fractions. Compounds 3, 4 and 5 were isolated from fraction 5 using MeOH: H 2 O, 2:3, followed by PPC using BAW as a solvent, and repeated Sephadex LH 20 column fractionation using H 2 O and H 2 O: MeOH of decreasing polarities for elution to yield the pure compounds 3 (10 mg), 4 (12 mg), and 5 (17 mg) as yellow amorphous powders.
